CVS Health unveils new PBM, pharmacy efforts to curb opioid abuse
WOONSOCKET, R.I. — CVS Health is continuing its fight against prescription drug misuse and abuse with efforts across its businesses. The company on Thursday announced enhanced enterprise-wide efforts to support drug disposal, manage pain medications and fund treatment and recovery programs.
“As America’s front door to health care with a presence in nearly 10,000 communities across the country, we see firsthand the impact of the alarming and rapidly growing epidemic of opioid addiction and misuse,” CVS Health president and CEO Larry Merlo said. “Today we are announcing an expansion of our enterprise initiatives to fight the opioid abuse epidemic that leverages CVS Pharmacy’s national presence with the capabilities of CVS Caremark, which manages medications for nearly 90 million plan members.”
Starting Feb. 1, 2018, CVS Health’s pharmacy benefits manager CVS Caremark will be implementing an enhanced opioid utilization management approach that will include limiting the supply of opioids for certain acute prescriptions to seven days for patients that are new to therapy. Other features of the initiative include limited the daily dosage of opioids dispensed based on the drug’s strength and requiring the use of immediate-release formulations before extended-release opioids are dispensed.
CVS Pharmacy locations will roll out a more robust patient counseling program for patients filling an opioid prescription, including an education program that will highlight opioid safety and the potential for addiction. The program will educate patients about prescribing guidelines from the Centers for Disease Control and Prevention encouraging the use of the lowest effective dose for the shortest time possible. They also will share with patients the importance of keeping medications secure at home and how to properly dispose of unused medication.
“Without a doubt, addressing our nation’s opioid crisis calls for a multipronged effort involving many health care stakeholders — from doctors, dentists and pharmaceutical companies to pharmacies and government officials,” Merlo said. “With this expansion of our industry-leading initiatives, we are further strengthening our commitment to help providers and patients balance the need for these powerful medications with the risk of abuse and misuse.”
CVS Health also will add in-store disposal units at 750 CVS pharmacy locations, bringing the total number of in-store units to 1,550. Such states as Florida, Massachusetts, North Carolina, Pennsylvania, South Carolina and the District of Columbia will begin seeing these in the fall. Besides providing the in-store disposal units, CVS Health has donated more than 800 medication disposal units to community police departments in the past several years. In the past two years, more than 100 metric tons of medication has been collected through the program.
“Everyone has a role to play in addressing the opioid epidemic, and CVS Health is showing how the private sector can help,” acting director of the Office of National Drug Control Policy Richard Baum said. “Making sure people can safely dispose of unwanted medications is a key part of preventing opioid misuse and abuse, and CVS Health has taken this important step which will support the health of communities across the country.”
Also as part of CVS Health’s expanded efforts, the CVS Health Foundation is adding $2 million to its commitment to mitigating prescription drug abuse through support for federally qualified community health centers that provide access to treatment and recovery services. Alongside the National Association of Community Health Centers, the foundation brought together a panel of experts to develop a protocol for best practices in community health centers on prescribing guidelines, medication-assisted treatment, behavioral health and community collaboration.
“Community health centers have the unique ability to leverage their care teams, health information technology systems and quality infrastructure to support drug abuse control in their communities,” NACHC president and CEO Tom Van Coverden said. “Through the Innovative Approaches for Prescription Drug Abuse Management and Prevention program, we hope to build capacity for providing integrated behavioral health services in communities with high incidence of substance use and abuse with the goal of implementing innovative, collaborative, and community‐based models that result in safe prescribing practices, care coordination, strengthened partnerships and non-judgmental environments for all patients.”
And CVS Health is expanding its Pharmacists Teach program’s audience with a new focus on parents. With its focus on teens, it has educated more than 295,000 students about prescription drug abuse. These efforts are in addition to CVS Pharmacy locations in 43 states offering prescription-free naloxone, and CVS Health’s advocacy for improving such tools as prescription drug monitoring programs.
Driving revenue streams with pharmacy technology
As the nation's healthcare system continues to evolve, community pharmacies are searching for new ways to attract patients and create new revenue opportunities. Because this has mostly meant expanding the services they offer, streamlining payment and reimbursement processes has taken on added importance.
"The average independent pharmacy has $180,000 of receivables at risk annually," said Lari Harding, VP of product marketing at Inmar, which offers a range of solutions to help retail pharmacies cope with the growing complexities of the claims and payment reconciliation process.
"A good reconciliation solution gathers 835 files and provides basic reporting so your staff can pursue collections," Harding said. "A best-in-class solution finds missing data, helps address slow payers, identifies collectible funds and even chases down unpaid claims so your pharmacy can recoup as much as possible."
Payment and reconciliation suppliers say the greatest challenges facing pharmacies today revolve around direct and indirect remuneration, or DIR, fees. Because pharmacies often do not have detailed insight into drug pricing and post-adjudication service fees, discount card fees and these DIR fees, they often are challenged to manage their revenue line.
"These fees are often taken back as lump sums in the 835 payment files, and claim-level detail is not provided," Harding said. "This makes it challenging to assess if the fees are fair and to use the data to improve your business."
Inmar is among a handful of tech companies that have joined forces to test ways to create more standards for reporting DIR fees.
"PBMs are under scrutiny to enable transparency to both the payers and the providers," Harding said. "Both new technology tools and new business practices will evolve to help better support true cost transparency. Consumers are bearing more of the costs and will demand to understand them. Payers will continue to evolve toward a value-based business model, which will also require the ability to see the full picture of costs and outcomes."
The quest to bring more transparency to DIR fees is just one of the changes afoot in the payment and reconciliation arena.
"We've seen payment reform on the prescriber side, but it was accomplished by requiring updated certified technology, allowing all providers active in the care of a patient to exchange and share data," said QS/1 retail interface analyst Crystal Ratliff. "The pharmacy side will not be different.”
"The vast majority of patients have multiple disease states and are not compliant with their medications," she said. "Decreased reimbursement for traditional dispensing services has created operational challenges for pharmacies, further emphasizing the need for payment-based enhanced services.”
QS/1 is among a handful of technology suppliers that are developing new methods that are not only making it easier for pharmacies to get paid for their efforts, but also are ensuring the security of the consumer credit card data they collect from the millions of transactions they process every day.
Last month, for example, the company announced that its point-of-sale systems now meet the guidelines of the Qualified Integrators and Resellers program.
“Research has proven that installations not done correctly can open the door for networks to be compromised,” QS/1 manager of systems development Chris Lewis said when the certification by the Payment Card Industry Data Security Standard was announced.
Those in the payment sector said that making pharmacies' systems more secure, and integrating them into the broader healthcare network, is crucial for the industry to enhance its standing with patients and payers.
"Technology, integration and interfaces are the way of the future; and not all interfaces or integrations are created equally," QS/1's Ratliff said. "Healthcare software systems must be prepared to communicate and share data with other systems across the patient care continuum."
Pharmacies leverage data to improve patient outcomes
Employing sophisticated technology and a broad range of customer information is central to community pharmacies' ongoing efforts to play a greater role in managing patients' health, according to industry sources.
"Besides capturing all of their prescription-related data, pharmacies should mine their patients’ point-of-sale data," Innovation VP of global business development Doyle Jensen told Drug Store News.
"Using both categories of data, pharmacies can better analyze their patients’ medication profiles and disease states combined with purchasing trends, and pinpoint potentially useful and discounted over-the-counter products, vitamins, nutraceuticals, durable medical equipment and so on," he said. "The POS system can then provide valuable coupons for discounts on these products during checkout, or pharmacy staff can make recommendations on products they believe could be helpful to patients."
Technology providers stress that offering a more comprehensive approach to patient care is essential for community pharmacies as they continue to seek ways to be part of a broad-based, team-focused patient care solution.
"With the pharmacist being one of the most accessible players on the healthcare team, being able to have a holistic view of the patient is key," LexisNexis – Health Care director of pharmacy Bobbie Riley said. "Being able to gain access within workflow to individual patient’s social determinants of health will help us tailor patient engagement strategies to improve adherence and drive more positive outcomes."
While using technology is helping pharmacies keep patients safe and compliant, it also is raising their profile as critical healthcare providers.
"Because front-end pharmacy operations are already overwhelmed, technology can be a key in minimizing wasted time and human error, and maximizing the pharmacist’s time for patient care," said Frank Maione, chief business officer at PreceptiMed, the creator of the VeriFill and IdentRx systems that help ensure prescription accuracy. "The automations and verifications that technology can provide in labor redeployment through remote applications and by reducing human error should result in long-term return on investment."
The impact technology can have on the bottom line and a pharmacy's standing in the healthcare continuum, Maione and others said, cannot be overstated.
"Not only is it a pharmacist’s passion to provide the best patient care, community pharmacies must be prepared to keep patients compliant and adherent because their five-star ratings depend on it," QS/1 retail interface analyst Crystal Ratliff said.
Such long-used technologies as automation, IVR and the ability to order refills online and via mobile apps, as well as more recent developments, such as electronic prescribing and telepharmacy, have made pharmacies more efficient and responsive to patients' needs, she noted. As a result, a growing number of patients across the country are relying on their neighborhood pharmacist for a wider range of healthcare services.
As technology gives community pharmacies the ability to be part of a collaborative healthcare team, outcomes are improving, and more patients are taking their medications properly.
"As pharmacists, we must collaborate with our software friends to provide us with the medication risk mitigation tool we need to effect change and eliminate adverse drug events," Tabla Rasa HealthCare CEO Calvin Knowlton said during a speech to the American Society for Automation in Pharmacy in July. "It is time to integrate the science that underlies our medication safety metrics into our pharmacy technology and systems."
Among the more recent tools developed to improve compliance is the recent alliance between LexisNexis Risk Solutions and eRx Network.
According to the companies, the partnership combines LexisNexis data on more than 8.5 million providers with eRx Network's real-time pharmacy network, letting pharmacies perform comprehensive prescription compliance checks in real-time. The solution, they noted, uses the existing pharmacy connectivity of eRx Network and requires little to no integration or maintenance by a pharmacy chain.